Aptose Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript
Well, good morning, everyone, and welcome to day two of the 2023 RBC Global Healthcare Conference. My name is Greg Renza, one of the biotechnology equity research analysts here at RBC, and we're pleased to have Aptose Biosciences with us this morning. And joining us from the company is Dr. William Rice, the Chairman, President and Chief Executive Officer.
Bill, it's great to see you, and thanks for being here.
You too, Greg. Thank you so much for the invitation to your conference, and it's actually wonderful to see everyone face-to-face again. And so, thanks again for having us here.
Absolutely. Makes a big difference. And it's always great to connect on your portfolio. A great deal going on with tuspetinib, and we always look forward to the data updates that you generate with the program and for patients every few times a year investment.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
